Ascentage Pharma (AAPG) - Pendapatan lan volume dodolan

Lambang korporat lan logo Ascentage Pharma (AAPG)

Ascentage Pharma Group is competing for leadership in the R&D race, protecting its positions through patents. Management is focusing on portfolio validation and partnerships, which is confirmed by the company's annual sales volume on the GURU.Markets terminal chart, where the value 0.09 records the metric level. The business relies on the high margins of patented drugs coupled with minimal production costs.

Pendapatan lan volume dodolan Ascentage Pharma Group (AAPG): kanggo periode 25.01.2025 - 15.11.2026

Rincian analitis perusahaan Ascentage Pharma Group

Analisis umum perusahaan:Ascentage Pharma Group, AAPG
Produk asli Ascentage Pharma Corp

This metric captures the daily cash inflow from product sales, reflecting the actual scale of the business's commercial expansion without data gaps. For Ascentage Pharma Group (AAPG), which is currently in an oncology drug development cycle, the company's sales figures allow investors to filter out market noise and assess the actual monetization of molecules, separating operational resilience from speculative expectations regarding clinical trial results.

Pesaing wigati

Pendapatan perusahaan ONC|Pendapatan lan volume dodolan HALO|RVMD (Revolution Medicines, Inc.) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan CGON (CG Oncology Inc)|Pendapatan dodolan perusahaan URGN|bicara.com - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan PSNL (personalis.com)|Erasca Inc (ERAS) - Pendapatan perusahaan|Dodolan perusahaan Delcath Systems|YMAB (YmAbs) - Pendapatan lan volume dodolan|AURA: Pendapatan dodolan perusahaan|Pendapatan perusahaan Candel Therapeutics, Inc. (CADL)|Pendapatan lan volume dodolan Accuray (ARAY)|Pendapatan perusahaan SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Total pendapatan perusahaan|CTOR - Pendapatan perusahaan|HURA: Pendapatan perusahaan|TARA (Protara) - Dodolan perusahaan|Fate Therapeutics, Inc. - Pendapatan dodolan perusahaan|WHWK (aadibio.com) - Pendapatan lan volume dodolan|TCRX: Pendapatan dodolan perusahaan|Pendapatan perusahaan Champions Oncology (CSBR)|XBiotech - Volume dodolan perusahaan|Pendapatan perusahaan CEL-SCI CVM|Pendapatan reged perusahaan OS Therapies (OSTX)|Radiopharm Theranostics Limited - Pendapatan lan volume dodolan|Total pendapatan perusahaan Artiva Biotherapeutics|ANL (adlainortye.com) - Dodolan perusahaan|Dodolan perusahaan Veru Pharma|TPST (Tempest Therapeutics Inc) - Pendapatan lan volume dodolan|Xilio Therapeutics, Inc. (XLO) - Pendapatan reged perusahaan|Pendapatan perusahaan Enochian BioSciences (RENB)|MURA: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan KAPA (kairospharma.com)|Pendapatan reged perusahaan OnKure (OKUR)|CytoMed Therapeutics Ltd - Pendapatan lan volume dodolan|curis.com (CRIS) - Dodolan perusahaan|Apollomics Corp (APLM) - Pendapatan perusahaan|Tharimmune - Pendapatan dodolan perusahaan|ADVB (Advanced Biomed Corp) - Pendapatan lan volume dodolan|Dodolan perusahaan Genprex, Inc (GNPX)|Pendapatan lan volume dodolan CLDI|SBFM: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan XBIO (xeneticbio.com)|Pendapatan lan volume dodolan Salarius Pharmaceuticals Inc SLRX|purple-biotech.com - Pendapatan lan volume dodolan|Total pendapatan perusahaan American Oncology Network, Inc.|BGNE: Pendapatan lan volume dodolan|Dodolan perusahaan checkpointtx.com|Pendapatan perusahaan Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Pendapatan reged perusahaan|Pendapatan perusahaan Ikena (IKNA)|NTBL - Total pendapatan perusahaan|Pendapatan perusahaan viracta.com VIRX|morphosys.com (MOR) - Total pendapatan perusahaan|NAYA Biosciences Inc - Pendapatan lan volume dodolan|AAPGV: Pendapatan perusahaan